Innovating cancer care access for low and middle-income countries
Dr Geraldo Alves speaks to ecancer about the COVID-19 pandemic in Brazil, and managing cancer patients at this time.
He initially discusses the current trends in his region of Brazil, but emphasises that in such a big country the situation is not homogenous.
Dr Alves also outlines his experience with the use of hydroxychloroquine, and some of the latest research regarding the use of this drug for coronavirus.
Please note that in April 2020 when this video was recorded, doctors were looking for any therapy which might help covid patients in an emergency setting. Since then some research has shown evidence that does not support the use of hydroxychloroquine.
Innovating cancer care access for low and middle-income countries
Key insights on breast cancer in Cape Verde
Addressing cancer control challenges in Africa
Empowering Women's Health: HPV screening and cervical cancer elimination in Pakistan
Gaza's cancer patients: Navigating the dual struggle of illness and war
Cancer in emergencies: What can we do better to protect the most vulnerable?
OncoAlert Round Up for September 15-21, 2023
The Vietnam National Cancer Institute’s efforts in improving cancer care in Vietnam
Time toxicity: the burden on cancer patients